Press Releases

Press Releases

Press Releases

Date Title and Summary Additional Formats
May 03, 2016
Genomic Health to Present at Bank of America Merrill Lynch 2016 Health Care Conference
REDWOOD CITY, Calif. , May 3, 2016 /PRNewswire/ --  Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits , Chairman of the Board, Chief Executive Officer and President, will present at the Bank of America Merrill Lynch 2016 Health Care Conference at the Encore at Wynn Las Vegas on
Apr 27, 2016
Genomic Health to Announce First Quarter 2016 Financial Results and Host Conference Call on Wednesday, May 4, 2016
REDWOOD CITY, Calif. , April 27, 2016 /PRNewswire/ --  Genomic Health, Inc.  (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, May 4 at 4:30 p.m. Eastern Time to discuss its first quarter 2016 financial results.  The call and webcast will follow
Mar 11, 2016
Genomic Health Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the Clinical Utility of Oncotype DX® in Node-positive and High-risk Node-negative Breast Cancer
One of the Largest Contemporary Adjuvant Breast Cancer Trials in Europe Shows that Patients with Low Oncotype DX® Scores Can Be Spared Chemotherapy Even When Traditional Factors Indicate Higher-Risk Disease
Mar 09, 2016
German National Cancer Guidelines Distinguish Oncotype DX® as First and Only Multi-gene Breast Cancer Test with 1A Level of Evidence
Updated Guidelines Elevate Evidence following Publication of Multiple Large Prospective Outcomes Studies
Mar 02, 2016
Genomic Health to Present at the Cowen and Company 36th Annual Health Care Conference
REDWOOD CITY, Calif. , March 2, 2016 /PRNewswire/ --  Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole , Chief Operating Officer and Chief Financial Officer, will present at the Cowen and Company 36 th Annual Health Care Conference at the Marriot Copley Place in Boston on
Mar 01, 2016
Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial Using Oncotype DX®
New Publication of Results from 'PlanB' Study Reinforces Unique Value of Oncotype DX, the Only Multi-gene Breast Cancer Test with Prospective Outcomes Evidence in More Than 50,000 Patients
Five-year Results Accepted for Oral Presentation at European Breast Cancer Conference, Included in Official Congress Press Program
Feb 10, 2016
Genomic Health Announces 2016 Financial Outlook and Provides 2015 Fourth Quarter and Year-End Financial Results
Expects to Deliver Double-Digit Test and Revenue Growth in 2016
Plans to Launch First Liquid Biopsy Test Mid-2016
Conference Call Today at 4:30 p.m. ET
Feb 03, 2016
Genomic Health to Announce Fourth Quarter and Year-End 2015 Financial Results and Host Conference Call on Wednesday, February 10, 2016
REDWOOD CITY, Calif. , Feb. 3, 2016 /PRNewswire/ -- Genomic Health , Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, February 10 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2015 financial results.
Jan 11, 2016
Genomic Health Announces Plans to Launch Liquid Biopsy Mutation Panel in 2016
REDWOOD CITY, Calif. , Jan. 11, 2016 /PRNewswire/ --  Genomic Health, Inc. (Nasdaq: GHDX) today announced plans to launch its first liquid biopsy test, Oncotype SEQ™, in mid-2016. The test is a blood-based mutation panel that uses next-generation sequencing to identify select actionable genomic
Jan 08, 2016
Genomic Health Announces Preliminary 2015 Revenue and Confirms 2016 Growth Expectations
REDWOOD CITY, Calif. , Jan. 8, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced preliminary revenue for the year ended December 31, 2015 , is expected to be between $285 and $286 million , compared with $275.7 million in 2014, representing an increase of approximately 4